Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III, Multicenter, Randomized, Double-blind, Controlled Study to Evaluate Pharmacokinetics, Safety and Efficacy of ADC189 Tablets/Granules in Children 2-11 Years Old With Influenza

Next Previous
Search
Trial Profile

A Phase III, Multicenter, Randomized, Double-blind, Controlled Study to Evaluate Pharmacokinetics, Safety and Efficacy of ADC189 Tablets/Granules in Children 2-11 Years Old With Influenza

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 03 Mar 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ADC 189 (Primary) ; Baloxavir-marboxil (Primary) ; Oseltamivir (Primary)
  • Indications Influenza A virus infections; Influenza B virus infections
  • Focus Adverse reactions
  • Sponsors Jiaxing AnDiCon Biotech

    • Most Recent Events

    • 19 Feb 2025 According to Simcere Pharmaceutical Group media release, study conducted across 35 clinical study sites nationwide in China, led by Professor Ni Xin and Professor Zhao Chengsong, President and Vice President of Beijing Children's Hospital, Capital Medical University, as the principal investigators.
    • 19 Feb 2025 Status changed from recruiting to to completed, according to Simcere Pharmaceutical Group media release. The company has completed the full patient enrollment and follow-up.
    • 13 Sep 2024 According to Simcere Pharmaceutical media release, Professor Ni Xin and Professor Zhao Chengsong are the principal investigators of the trial.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top